logo
Share SHARE
FONT-SIZE Plus   Neg

PerkinElmer Completes ShanghaiHaoyuan Biotech Acquisition

PerkinElmer, Inc. (PKI) Monday said it has completed the acquisition of ShanghaiHaoyuan Biotech Co., Ltd., a China-based infectious disease diagnostics company.

The Haoyuan acquisition enables PerkinElmer to supply advanced, highly sensitive diagnostics screenings to these banks, ensuring that HBV, HCV and HIV are accurately detected prior to transfusion.

Simultaneously, this product integration strengthens the safety of the blood banks in China while creating an opportunity for future implementation in other countries.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Activision Blizzard Inc. (ATVI) on Thursday reported a drop in profit for the fourth quarter, as revenues declined reflecting weak demand for Skylanders SuperChargers and Guitar Hero Live. The video game publisher's profit and revenues fell short of Wall Street estimates. Moving ahead, the company detailed... CBS Corp. (CBS, CBS-A) Thursday reported a drop in profit for the fourth quarter, hurt largely by one-time charges. However, on an adjusted basis, earnings for the three-month period increased on higher revenues across all major segments, except local broadcasting division. The New York-based company's... Tesla's next electric car Model 3 is aimed at the masses with a price tag that could go below $30,000. Tesla CEO Elon Musk, during an earnings call, confirmed that the Model 3 will start selling for "around $35k," and reservations will start from March 31 in Tesla stores and online on April 1 for...
comments powered by Disqus
RELATED NEWS
Trade PKI now with 
Follow RTT